Advertisement

ARIKAYCE (amikacin liposome inhalation suspension)

No Defense - 1

NEW YORK
2019
2019
Entrant Company
Area 23, An FCB Health Network Company
Medium
Print & Out of Home Technique (Pharmaceutical)
Category
Art Direction
Entry Type
Direct-to-Professionals
Thumbnail for No Defense - 1
View Fullscreen

Items

Credits
Agency NetworkFCB Health Network
Advertiser BrandInsmed - ARIKAYCE, Bridgewater, NJ
Entrant CompanyArea 23, An FCB Health Network Company, New York
Animation CompanyZombie Studio, São Paulo
CCOTim Hawkey / Area 23, An FCB Health Network Company
SVP, Group Creative DirectorChris Bernesby / Area 23, An FCB Health Network Company
SVP, Creative DirectorJoe Capanear / Area 23, An FCB Health Network Company
VP, Creative DirectorMike McKeever / Area 23, An FCB Health Network Company
VP, Associate Creative DirectorZuzana Zaloudek / Area 23, An FCB Health Network Company
Group Art SupervisorOlga Demeshchik / Area 23, An FCB Health Network Company
ProducerRenee Jung / Area 23, An FCB Health Network Company
SVP, Group Management DirectorRobb Brady / Area 23, An FCB Health Network Company
VP, Account DirectorMartha Simpson / Area 23, An FCB Health Network Company
Account DirectorJack O’Shaughnessy / Area 23, An FCB Health Network Company
Strategic Planning DirectorGreg Yellin / Area 23, An FCB Health Network Company
CGI DesignZombie Studios / Zombie Studios
TypographerKevin Cantrell
Typography ProducerErik Attkisson

This 2019 Clio Health Bronze winning entry titled 'No Defense - 1' was entered for ARIKAYCE (amikacin liposome inhalation suspension) by Area 23, An FCB Health Network Company, New York, part of agency network: FCB Health Network. The piece was submitted to the medium: Print & Out of Home Technique (Pharmaceutical) within the entry type: Direct-to-Professionals and the category: Art Direction.

Advertisement
Advertisement